CEA Tumor Relationship in Patients with Colorectal Carcinoma

2023

Closed access Metadata (CSL-JSON)
DOI 10.33745/ijzi.2023.v09i01.069
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Cancer is the name given to abnormal and unregulated growth of cells which multiply in an uncontrolled and unabated way and, in some cases, to metastasize.Colorectal cancer (CRC) is a dreadful health problem worldwide.Tumor markers are assuming an important role in all aspects of cancer care and have an impact on early diagnosis, prognosis and screening for malignancy in asymptomatic groups.There is no "universal" tumor marker that can detect all types of cancer.Our study was case control study including patients attending to Department of Surgical Oncology and Biochemistry, Faculty of Medicine, West Kazakhstan Marat Ospanove State Medical University Aktobe Kazakhstan.50 CRC patients, with no other cancer, 19 males (38%) and 31 females (62%), their ages between 20-70 years were studied.The present study demonstrated that the mean age value for 50 studied CRC patients was 52.9 ± 10.54 years.Carcinoembryonic antigen (CEA) showed a highly statistically significant difference between cases and controls.In the present study, the serum levels of tumor marker CEA were statistically higher in diagnosed cases of colorectal carcinoma as compared to the controls showing the importance of the CEA marker in colorectal cancer.Findings of this study further strengthen the position of tumor markers in diagnosis, prognosis and detection of recurrences of the tumor.